Grifols SA (GRFS)
6.57
+0.18
(+2.82%)
USD |
NASDAQ |
May 03, 16:00
6.575
0.00 (0.00%)
After-Hours: 20:00
Grifols Shareholders Equity (Quarterly): 6.441B for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 6.441B |
| September 30, 2023 | 6.486B |
| June 30, 2023 | 6.370B |
| December 31, 2022 | 6.574B |
| June 30, 2022 | 6.612B |
| June 30, 2021 | 6.150B |
| March 31, 2021 | 6.357B |
| December 31, 2020 | 6.283B |
| September 30, 2020 | 6.278B |
| June 30, 2020 | 6.034B |
| March 31, 2020 | 6.114B |
| December 31, 2019 | 5.402B |
| September 30, 2019 | 5.221B |
| June 30, 2019 | 4.996B |
| March 31, 2019 | 4.942B |
| December 31, 2018 | 4.834B |
| September 30, 2018 | 4.817B |
| June 30, 2018 | 4.587B |
| March 31, 2018 | 4.568B |
| December 31, 2017 | 4.354B |
| September 30, 2017 | 4.221B |
| June 30, 2017 | 4.094B |
| March 31, 2017 | 4.072B |
| December 31, 2016 | 3.934B |
| Date | Value |
|---|---|
| September 30, 2016 | 3.958B |
| June 30, 2016 | 3.791B |
| March 31, 2016 | 3.732B |
| December 31, 2015 | 3.604B |
| September 30, 2015 | 3.599B |
| June 30, 2015 | 3.443B |
| March 31, 2015 | 3.391B |
| December 31, 2014 | 3.232B |
| September 30, 2014 | 3.216B |
| June 30, 2014 | 3.045B |
| March 31, 2014 | 3.053B |
| December 31, 2013 | 2.902B |
| September 30, 2013 | 2.648B |
| June 30, 2013 | 2.524B |
| March 31, 2013 | 2.506B |
| December 31, 2012 | 2.482B |
| September 30, 2012 | 2.389B |
| June 30, 2012 | 2.278B |
| March 31, 2012 | 2.240B |
| December 31, 2011 | 2.153B |
| September 30, 2011 | 2.168B |
| June 30, 2011 | 2.172B |
| December 31, 2010 | 921.72M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
4.996B
Minimum
Jun 2019
6.612B
Maximum
Jun 2022
6.094B
Average
6.280B
Median
Shareholders Equity (Quarterly) Benchmarks
| DBV Technologies SA | 140.19M |
| Adaptimmune Therapeutics PLC | 39.51M |
| Akari Therapeutics PLC | -0.229M |
| Biodexa Pharmaceuticals Plc | 5.959M |
| NuCana PLC | 18.96M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 23.70B |
| Total Liabilities (Quarterly) | 14.89B |
| Debt to Equity Ratio | 1.546 |
| Current Ratio | 2.786 |
| Net Debt Paydown Yield | -2.78% |